Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Non-Current Assets: 2020-2025

Historic Non-Current Assets for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $3,988.

  • Molecular Partners Ag's Non-Current Assets fell 26.18% to $3,988 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,988, marking a year-over-year decrease of 26.18%. This contributed to the annual value of $4.8 million for FY2024, which is 26.43% down from last year.
  • Latest data reveals that Molecular Partners Ag reported Non-Current Assets of $3,988 as of Q3 2025, which was down 10.43% from $4,452 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Non-Current Assets peaked at $9.2 million during Q4 2021, and registered a low of $3,988 during Q3 2025.
  • For the 3-year period, Molecular Partners Ag's Non-Current Assets averaged around $1.0 million, with its median value being $6,208 (2024).
  • Data for Molecular Partners Ag's Non-Current Assets shows a maximum YoY decreased of 27.03% (in 2024) over the last 5 years.
  • Molecular Partners Ag's Non-Current Assets (Quarterly) stood at $9.2 million in 2021, then decreased by 15.25% to $7.8 million in 2022, then fell by 14.73% to $6.6 million in 2023, then dropped by 27.03% to $4.8 million in 2024, then fell by 26.18% to $3,988 in 2025.
  • Its Non-Current Assets stands at $3,988 for Q3 2025, versus $4,452 for Q2 2025 and $4,609 for Q1 2025.